SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001168220-15-000024
Filing Date
2015-04-01
Accepted
2015-04-01 08:00:53
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A 06/30/2014 form10qa_063014.htm 10-Q/A 1037836
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER ex_31-1.htm EX-31.1 17517
3 CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER ex_31-2.htm EX-31.2 17501
4 CERTIFICATION CHIEF EXECUTIVE OFFICER ex_32-1.htm EX-32.1 8613
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex_32-2.htm EX-32.2 8738
  Complete submission text file 0001168220-15-000024.txt   10178604

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ulu-20140630.xml EX-101.INS 1386036
7 XBRL TAXONOMY EXTENSION SCHEMA ulu-20140630.xsd EX-101.SCH 69757
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ulu-20140630_cal.xml EX-101.CAL 67656
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ulu-20140630_def.xml EX-101.DEF 336078
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ulu-20140630_lab.xml EX-101.LAB 878608
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ulu-20140630_pre.xml EX-101.PRE 503397
Mailing Address 4452 BELTWAY DRIVE ADDISON TX 75001
Business Address 4452 BELTWAY DRIVE ADDISON TX 75001 214-905-5145
ULURU Inc. (Filer) CIK: 0001168220 (see all company filings)

IRS No.: 412118656 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-33618 | Film No.: 15741344
SIC: 2834 Pharmaceutical Preparations